# Amphastar Pharmaceuticals, Inc. (AMPH) FY2026 Q2 P&L / Income Statement

- Company: Amphastar Pharmaceuticals, Inc. (AMPH)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001297184-26-000047
- Page: https://plicit.ai/financials/amph/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/amph-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Subsegment

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Subsegments. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 183,903,000 US dollars
- **Cost of revenues**: 90,433,000 US dollars
- **Gross profit**: 93,470,000 US dollars
- **Total operating expenses**: 53,741,000 US dollars
- **Income from operations**: 39,729,000 US dollars
- **Total non-operating income (expenses), net**: negative 1,185,000 US dollars
- **Income before income taxes**: 38,544,000 US dollars
- **Income tax provision**: 8,196,000 US dollars
- **Net income**: 30,348,000 US dollars
- **Finished Pharmaceutical Products Segment - BAQSIMI**: 45,503,000 US dollars
- **Finished Pharmaceutical Products Segment - Epinephrine**: 15,854,000 US dollars
- **Finished Pharmaceutical Products Segment - Glucagon**: 11,905,000 US dollars
- **Finished Pharmaceutical Products Segment - Ipratropium Bromide**: 8,411,000 US dollars
- **Finished Pharmaceutical Products Segment - Lidocaine**: 15,039,000 US dollars
- **Finished Pharmaceutical Products Segment - Other Products**: 66,187,000 US dollars
- **Finished Pharmaceutical Products Segment - Primatene MIST**: 21,004,000 US dollars
- **Research and development**: 22,164,000 US dollars
- **General and administrative**: 18,242,000 US dollars
- **Selling, distribution, and marketing**: 13,335,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/amph/fy2026-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/amph-fy2026-q2-revenue-by-geography-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 183,903,000 US dollars
- **Cost of revenues**: 90,433,000 US dollars
- **Gross profit**: 93,470,000 US dollars
- **Total operating expenses**: 53,741,000 US dollars
- **Income from operations**: 39,729,000 US dollars
- **Total non-operating income (expenses), net**: negative 1,185,000 US dollars
- **Income before income taxes**: 38,544,000 US dollars
- **Income tax provision**: 8,196,000 US dollars
- **Net income**: 30,348,000 US dollars
- **United States**: 172,342,000 US dollars
- **China**: 4,560,000 US dollars
- **France**: 7,001,000 US dollars
- **Research and development**: 22,164,000 US dollars
- **General and administrative**: 18,242,000 US dollars
- **Selling, distribution, and marketing**: 13,335,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.